$KERX Keryx Biopharmaceuticals (KERX) Overall Average: 88% Buy.

Wrapping Up a Half-Decay of Environmental Commitment PG&E has been playing the long game with its environmental initiatives, and this wraps up a five-year saga that's worth dissecting. The PG&E Corporation Foundation has doled out its final set of grants, making a 25-strong lineup of eco-friendly campaigns. We're talking $500,000 split among five organizations trying to...

Okta Leaps to S&P 500: A Power Play You blink for a second, and boom, Okta's sitting at the big kids' table—the S&P 500. You know how rare that move is? It’s like snagging an invite to the party everyone wants to attend. Swapping out Kenvue Inc. (NYSE: KVUE), which Kimberly-Clark (NASD: KMB) is scooping up, Okta's maneuver signifies a hefty endorsement of its growth...

Traders and their AI tools—sounds like a match made in market heaven, right? That's the buzz coming out of BingX, the multi-asset trading platform that's been shaking things up in the fintech realm. These days, it seems like everyone's hitching a ride on the AI train. Explosive Growth in AI Utilization Now, let's talk numbers, and boy, are these numbers juicy. Daily...

Art Meets Animation: Glander's Inspiring Visit In the offbeat, winding world of creativity, Julian Glander's name rings some serious bells. This Pittsburgh-based powerhouse, known for his whimsical animations and illustrations, is heading to Rocky Mountain College of Art + Design (RMCAD) for the 2026/2027 Friction Series. It's happening November 10—pencil that in...

New hires in biotech often get more than just a desk and a computer—they might just snag a piece of the company pie, too. Actinium Pharmaceuticals, the folks dabbling in the mysterious world of targeted radiotherapies, pulled a classic move in welcoming a fresh face to their roster. On October 26, 2026, they rolled out an inducement stock option, a juicy carrot to lure...

Trailblazing in the Evolving EMS Arena SMTC's latest accolade from Frost & Sullivan isn't just another feather in their cap. It's a testament to how this mid-tier electronics manufacturing services (EMS) player stands head and shoulders above the rest. While other companies are fumbling with supply chain headaches and shifting market demands, these folks are buckling down...

Shareholders Fret Over Maplebear's Proposed Transaction It ain't every day a deal's got shareholders fidgeting more than a cat in a dog park, but here we are. Maplebear Inc. (NASDAQ: CART) finds itself under the magnifying glass as the seasoned crew over at Monteverde & Associates PC sound the alarm bells. The firm, sitting cozy in the Empire State Building, is on the...

ADT Shareholders on High Alert Listen up, folks. Anyone holding shares in ADT Inc. (NYSE: ADT) needs to sharpen their pencils and start crunching numbers. This isn't the time to sit back and coast. A M&A Class Action investigation is brewing, and it's centered on ADT's sale to Thrive Holdings. The $10.00 per share buyout offer might look neat and tidy, but there's more to...

Blue Moon Metals' Acquisition Detour Blue Moon Metals Inc. (NASDAQ: BMM), a name that's been stirring up chatter for its ambitious mining ventures, has waved goodbye to its planned acquisition of 33 U.S.-based tungsten and antimony projects. This move, announced on October 30, 2026, may have caught some investors off guard. The acquisition sounded like a good fit: a...

A New England Delicacy Rolling into Arkansas Folks in Northwest Arkansas are about to get a bite of the coast, and it's a big deal for any foodie out there who craves that authentic, no-frills lobster experience. Cousins Maine Lobster is setting out on a pop-up tour—a whirlwind of five days from November 11-15—bringing their joy-inducing lobster rolls straight from...

Exciting Updates on Palazestrant and Ribociclib Combination Recent discussions revolving around Palazestrant, especially in conjunction with ribociclib, have unveiled promising clinical activities. Patients suffering from estrogen receptor-positive and human epidermal growth factor receptor 2-negative (ER+/HER2-) advanced or metastatic breast cancer have shown significant...

Introduction to Purple Biotech and CAPTN-3 Purple Biotech is making significant strides in the field of cancer therapy with its innovative tri-specific antibody platform known as CAPTN-3. This technology employs a conditionally activated mechanism that engages T cells and NK cells, which are crucial components of the immune system, to enhance the body’s ability to fight...

Important Information for Shareholders of Xerox Holdings Corporation New York, November 26, 2024 - The Gross Law Firm is reaching out to shareholders of Xerox Holdings Corporation (NASDAQ: XRX) to discuss potential class actions related to recent events. This notice is essential for investors who purchased XRX shares within a specified timeframe. Why Contact The Gross Law...

Understanding RTX's Impressive Stock Surge RTX (NYSE: RTX) stock is experiencing a notable rise in early 2026, buoyed by strong performance levels and significant capital returns. The defense and aerospace leader appears poised for further gains, as projections for 2026 indicate a robust uptrend. The defense sector has shown remarkable strength, sustaining growth...

Unveiling the Growth of Carlisle Companies Carlisle Companies, identified by ticker CSL, has demonstrated an exceptional performance in the stock market over the past five years. With an impressive annualized return of 25.83%, its growth trajectory outpaces the average market performance by 11.8%. As of now, the company's market capitalization stands at a notable $16.34...